Physician profile
Tiffany La
NPI 1720575913
$958.53
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $21.57 · 2021: $201 · 2022: $206 · 2024: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327 · Education: $55.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.80 |
| Education | $55.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $256.76 | 2024 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $245.92 | 2021-2024 | |
| Coopervision INC. | $176.79 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $147.90 | 2019 | |
| Alcon Vision LLC | $45.46 | 2021-2022 | |
| Visioneering Technologies, INC. | $23.69 | 2021 | |
| Sun Pharmaceutical Industries INC. | $21.57 | 2020 | |
| Eyevance Pharmaceuticals LLC | $21.39 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $19.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany La listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.